I see where you are coming from, but the pharmacy industry doesn't like speculation. Prove you can treat 4 or tell them you can treat 20.
To prove that 20 would take astrinomical funds and trails.
I don't work in a lab, but I get the feeling the indications picked, do also prove a broader range of treatments without actually saying so. But that's my speculation.
Ann: 2023 Results webinar, page-118
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.62 |
Change
-0.240(1.15%) |
Mkt cap ! $2.635B | |||
| Open | High | Low | Value | Volume |
| $20.45 | $20.62 | $20.26 | $4.698M | 229.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 221 | $20.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.62 | 1553 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |